CT’s Protein Sciences arming for bird-flu vaccine
Contributed photo
Protein Sciences large-scale manufacturing facility in Pearl River, N.Y.
Meriden flu-vaccine maker Protein Sciences says it is ramped up and ready to produce enough quantities of vaccine as necessary to prevent a pandemic from the deadly H7N9 bird flu virus that has taken root in China.
The company claims that in just 100 days, it renovated and outfitted Pfizer Inc.’s former Pearl River, N.Y., facility to produce three lots of antigens for its Flublok brand seasonal anti-flu treatment that won federal approval back in January.
Related articles
- Australian bird flu vaccine trial results “promising” (matthewditrolio79.wordpress.com)
- FDA approves flu vaccine w/o eggs, viruses, or thimerosal (garberslife.wordpress.com)
- East Coast Life Sciences Roundup: GSK, Protein Sciences, IMS Health (xconomy.com)
- FDA approves new seasonal influenza vaccine made using novel technology (gloucestercitynews.net)
- Congress May Tax Flu Vaccines (drudge.com)
- Exercise boosts flu shots (sciencealert.com.au)
- A universal flu vaccine – could it be possible one day? (suzannevickers.scienceblog.com)
- Several Nurses Fired For Refusing Flu Shot (occupycorporatism.com)
- U.S. Says Following New Bird Flu Closely, Preparing Vaccine (nlm.nih.gov)
- U.S. says following new bird flu closely, preparing vaccine (news.terra.com)
